Foghorn Therapeutics Inc (FHTX) support and resistance · rev $22.6M
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
This page maps Foghorn Therapeutics Inc (FHTX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported FHTX revenue for 2024-12-31 was $22.6M. Net income was -$86.6M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. FHTX currently screens at market cap $237.8M.
FHTX currently screens at market cap $237.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new FHTX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the FHTX quote page for the session range and the stock page for the full model.
Not investment advice.